Dominantly inherited peripheral neuropathies

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 7, 2003, Pages 699-714

  Vallat, Jean Michel ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Charcot Marie Tooth; Hereditary sensory motor neuropathy; Peripheral neuropathy

Indexed keywords

AUTOSOMAL DISORDER; AUTOSOMAL DOMINANT DISORDER; CHARCOT MARIE TOOTH DISEASE 1; CHARCOT MARIE TOOTH DISEASE 1A; CHARCOT MARIE TOOTH DISEASE 1B; CHARCOT MARIE TOOTH DISEASE 2; CHARCOT MARIE TOOTH DISEASE X; DEMYELINATION; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; DNA DETERMINATION; DOMINANT INHERITANCE; ELECTROPHYSIOLOGY; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSY; HUMAN; MOLECULAR BIOLOGY; NERVE BIOPSY; NERVE FIBER DEGENERATION; NEUROPATHY; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; REVIEW; X CHROMOSOME LINKED DISORDER;

EID: 0038504662     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.7.699     Document Type: Review

References (80)

1. Charcot JM, Marie P. Sur une forme particulière d'atrophie musculaire progressive, souvent familiale, débutant par les pieds et les jambes et atteignant plus tard les mains. Rev Neurol 1886;6:97-138
2. Tooth HH. The peroneal type of progressive muscular atrophy. Thesis, HK Lewis, University of Cambridge, London, 1886
3. Ouvrier RA, McLeod JG, Pollard JD. Peripheral neuropathy in childhood. Second edition. Sydney: Mac Keith Press, 1999
4. Gilliatt RW, Thomas PK. Extreme slowing of nerve conduction in peroneal muscular atrophy. Ann Phys Med 1957;15:104-7
5. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiological findings in hereditary polyneuropathies. Arch Neurol 1968;18:603-18
6. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiological findings in various neuronal degenerations. Arch Neurol 1968;18:619-25
7. Thomas PK, Calne DB, Steward G. Hereditary motor and sensory polyneuropathy (peroneal muscular atrophy). Ann Hum Genet 1974;38:111-53
8. Chaouch M, Allal Y, De Sandre-Giovannoli A, et al. The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene. Neuromuscul Disord 2003;13:60-67
9. Boerkoel CF, Takashima H, Garcia CA, et al. Charcot-Marie-Tooth disease and related neuropathies: Mutation distribution and genotype-phenotype correlation. Ann Neurol 2002;51:190-201
10. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980;103:259-80
11. Lewis RA, Sumner AJ. Electrophysiologic features of inherited demyelinating neuropathies: A reappraisal. Ann N Y Acad Sci 1999:883:321-35
12. Nara T, Akashi M, Nonaka I, et al. Muscle and intramuscular nerve pathology in congenital hypomyelination neuropathy. J Neurol Sci 1995;129:170-74
13. Fabrizi GM, Simonati A, Taioli F, et al. PMP22 related congenital hypomyelination neuropathy. J Neurol Neurosurg Psychiatry 2001;70:123-26
14. Sindou P, Anani T, Garbay B, Couratier P, Lagrange E, Vallat JM. Implications des protéines myéliniques dans les neuropathies héréditaires. Rev Neurol 1999;155:97-110
15. Garbay B, Heape AM, Sargueil F, Cassagne C. Myelin synthesis in the peripheral nervous system. Progress Neurobiol 2000;61:267-304
16. Arroyo EJ, Scherer SS. On the molecular architecture of myelinated fibers. Histochem Cell Biol 2000;131:1-18
17. Lupski JM, De Oca-Luna RM, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-32
18. Vallat JM, Sindou P, Preux PM, et al. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 1996;39:813-17
19. Nishimura T, Yoshikawa H, Fujimura H, Sakoda S, Yanagihara T. Accumulation of peripheral myelin protein 22 in onion bulbs and Schwann cells of biopsied nerves from patients with Charcot-Marie-Tooth disease type 1A. Acta Neuropathol 1996;92:454-60
20. Roa BB, Garcia CA, Suter U, et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993;329:96-101
21. Vallat JM, Sindou P, Garbay B, et al. Expression of myelin proteins in the adult heterozygous Trembler mouse. Acta Neuropathol 1999;98:281-87
22. D'Urso D, Prior R, Greiner-Petter R, Gabreëls-Festen AAWM, Mueller HW. Overloaded endoplasmic reticulum-golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci 1998;18:731-40
23. D'Urso D, Ehrhardt P, Müller HW. Peripheral myelin protein 22 and protein zero: A novel association in peripheral nervous system myelin. J Neurosci 1999;19:3396-3403
24. Fabrizi GM, Simonati A, Morbin M, et al. Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: A cross-sectional morphometric and immunohistochemical study in twenty cases. Muscle Nerve 1998;21:869-77
25. Gabreëls-Festen AAWM, Bolhuis PA, Hoogendijk JE, Valentijn LJ, Eshuis EJHM, Gabreëls FJM. Charcot-Marie-Tooth disease type 1A: Morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol 1995;90:645-9
26. Sahenk Z, Chen L, Mendell JR. Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 1999;45:16-24
27. Kamholz J, Menichella D, Jani A, et al. Charcot-Marie-Tooth disease type 1: Molecular pathogenesis to gene therapy. Brain 2000;123:222-33
28. Levy BK, Fenton GA, Loaiza S, Hayat GR. Unexpected recovery in a newborn with severe hypomyelinating neuropathy. Pediatr Neurol 1997;16:245-48
29. Ghamdi M, Armstrong DL, Miller G. Congenital hypomyelinating neuropathy: A reversible case. Pediatr Neurol 1997;16:71-73
30. Bird TD, Ott J, Giblett ER. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Gen 1982;34:388-94
31. Bird TD, Kraft GH, Lipe HP, Kenney KL, Sumi SM. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: A 20-year study. Ann Neurol 1997;41:463-69
32. Donaghy M, Sisodiya SM, Kennet R, McDonald B, Haites N, Bell C. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J Neurol Neurosurg Psychiatry 2000;69:799-805
33. Xu W, Manichella D, Jiang H. Absence of PO leads to the dysregulation of myelin gene expression and myelin morphogenesis. J Neurosci Res 2000;60:714-24
34. Sindou P, Vallat JM, Chapon F. Ultrastructural protein zero expression in Charcot-Marie-Tooth type 1B disease. Muscle Nerve 1999;22:99-104
35. Gabreëls-Festen AAWM, Hoogendijk JE, Meijerink PHS, et al. Two divergent types of nerve pathology in patients with different PO mutations in Charcot-Marie-Tooth disease. Neurology 1996;47: 761-65
36. Lagueny A, Latour P, Vital A, et al. Peripheral myelin modification in CMT 1B correlates with MPZ gene mutations. Neuromusc Dis 1999;9:361-67
37. Vital C, Gherardi R, Vital A, et al. Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathol 1994;87:302-7
38. Vallat JM, Tabaraud F, Sindou P, Preux PM, Vandenberghe A, Steck A. Myelin widenings and MGUS-IgA: An immunoelectron microscopic study. Ann Neurol 2000;47:808-11
39. Thomas FP, Lebo RV, Rosoklija G, et al. Tomaculous neuropathy in chromosome 1 Charcot-Marie-Tooth syndrome. Acta Neuropathol 1994;87:91-97
40. Dayan AD, Graveson GS, Robinson PK, Woodhouse MA. Globular neuropathy. A disorder of axons and Schwann cells. J Neurol Neurosurg Psychiatry 1968;31:552-60
41. Vallat JM, Gil R, Leboutet MJ, Hugon J, Moulies D. Congenital hypo- and hypermyelination neuropathy. Two cases. Acta Neuropathol 1987;74:197-201
42. Umehara F, Takenaga S, Nakagawa M, et al. Dominantly inherited motor and sensory neuropathy with excessive myelin folding complex. Acta Neuropathol 1993;86:602-8
43. Nakagawa M, Suehara M, Saito A, et al. A novel MPZ gene mutation in dominantly inherited neuropathy with focally folded myelin sheaths. Neurology 1999;52:1271-75
44. Sander S, Ouvrier RA, McLeod JG, Nicholson GA, Pollard JD. Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry 2000;68:483-88
45. Street VA, Bennett CL, Goldy JD, et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003;60:22-26
46. Warner LE, Mancias P, Butler IJ, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998;18:382-84
47. Bergoffen J, Troffater J, Pericak-Vance MA, Haines JL, Chance PF, Fischbeck KH. Linkage localization of X-linked Charcot-Marie-Tooth disease. Am J Hum Genet 1993;52:312-18
48. Paulson HL, Garbern JY, Hoban TF, et al. Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease. Ann Neurol 2002;52:429-34
49. Scherer SS, Xu YT, Nelles E, Fischbeck K, Willecke K, Bone LJ. Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 1998;24:8-20
50. Hahn AF, Ainsworth PJ, Bolton CF, Bilbao JM, Vallat JM. Pathological findings in the X-linked form of Charcot-Marie-Tooth disease: A morphometric and ultrastructural analysis. Acta Neuropathol 2001;101:129-39
51. Kuntzer T, Dunand M, Schorderet DF, Vallat JM, Hahn AF, Bogousslavsky J. Phenotypic expression of a Pro 87 to Leu mutation in the connexine 32 gene in a large Swiss family with Charcot-Marie-Tooth neuropathy. J Neurol Sci 2003; in press.
52. Senderek J, Hermanns B, Bergmann C, et al. X-linked dominant Charcot-Marie-Tooth neuropathy: Clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations. J Neurol Sci 1999;167:90-101
53. Vital A, Ferrer X, Lagueny A, et al. Histopathological features of X-linked Charcot-Marie-Tooth disease in 8 patients from 6 families with different connexin 32 mutations. J Periph Nerv Syst 2001;6:79-84
54. Tabaraud F, Lagrange E, Sindou P, Vandenberghe A, Levy N, Vallat JM. Demyelinating X-linked Charcot-Marie-Tooth disease: Unusual electrophysiological findings. Muscle Nerve 1999;22:1442-47
55. Fischbeck KH, Ar Rushdi N, Pericak-Vance M, Rozear MP, Roses AD, Fryns JM. X-linked neuropathy: Gene localization with DNA probes. Ann Neurol 1986;20:527-32
56. Rozear MP, Pericak-Vance MA, Fischbeck K, et al. Hereditary motor and sensory neuropathy X-linked: A half century follow up. Neurology 1987;37:1460-65
57. Hahn AF. Hereditary motor and sensory neuropathy: HMSN type II (neuronal type) and X-linked HMSN. Brain Pathol 1993;3:147-55
58. Georgiou DM, Zidar J, Korosec M, Middleton LT, Kyriakides T, Christodoulou K. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 2002;4:93-96
59. Ben Othmane K, Middleton LT, Loprest LJ, et al. Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 1993;17:370-75
60. Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ. Cell 2001; 105:587-97
61. Saito M, Hayashi Y, Suzuki T, Tanaka H, Hozumi I, Tsuji S. Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. Neurology 1997;49:1630-35
62. Muglia M, Zappia M, Timmerman V, et al. Clinical and genetic study of a large Charcot-Marie-Tooth type 2A family from southern Italy. Neurology 2001;56:100-103
63. Kwon JM, Elliott JL, Yee WC, et al. Assignement of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 1995;57:853-58
64. De Jonghe P, Timmerman V, FitzPatrick D, Spoelders P, Martin JJ, Van Broeckhoven C. Mutilating neuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family. J Neurol Neurosurg Psychiatry 1997;62:570-73
65. Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003;72:722-27
66. Auer-Grumbach M, De Jonghe P, Wagner K, Verhoeven K, Hartung HP, Timmerman V. Phenotype-genotype correlations in a CMT2B family with refined 3q13-q22 locus. Neurology 2000;55:1552-57
67. Dyck PJ, Litchy WJ, Minnerath S, et al. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 1994;35:608-15
68. Yoshioka R, Dyck PJ, Chance PF. Genetic heterogeneity in Charcot-Marie-Tooth neuropathy type 2. Neurology 1996;46:569-71
69. Santoro L, Manganelli F, Di Maio L, et al. Charcot-Marie-Tooth disease type 2C: A distinct genetic entity. Clinical and molecular characterization of the first European family. Neuromusc Dis 2002;12:399-404
70. Ionasescu V, Searby C, Sheffield VC, Roklina T, Nishimura D, Ionasescu R. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Gen 1996;5:1373-75
71. Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000;60:37-46
72. De Jonghe P, Mersiyanova I, Nelis E, et al. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol 2001;49:245-49
73. Zhu Q, Couillard-Després S, Julien JP. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol 1997;148:299-316
74. Ismailov SM, Fedotov VP, Dadali EL, et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21. Eur J Hum Genet 2001;9:646-50
75. Takashima H, Nakagawa M, Nakahara K, et al. A new type of hereditary motor and sensory neuropathy linked to chromosome 3. Ann Neurol 1997;41:771-80
76. Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998;50:1397-1401
77. Chapon F, Latour P, Diraison P, et al. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry 1999;66:779-82
78. Pareyson D. Charcot-Marie-Tooth disease and related neuropathies: Molecular basis for distinction and diagnosis. Muscle Nerve 1999;22:1498-1509
79. Hattori N, Yamamoto M, Yoshihara T, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): A clinicopathological study of 205 Japanese patients. Brain 2003;126:134-51
80. Maier M, Berger P, Suter U. Understanding Schwann cell-neuron interactions: The key to Charcot-Marie-Tooth disease? J Anat 2002;200:357-66